Yan Zeng

4 ta ish

University of Chinese Academy of Sciences

1. Design, synthesis, in vitro evaluation of a new pyrrolo[1,2‐<i>a</i>]thiazolo[5,4‐<i>d</i>]pyrimidinone derivatives as cholinesterase inhibitors against Alzheimer's disease

   Yan Zeng, Lifei Nie, Liu Liu +6

   MaqolaCholinesterase and Neurodegenerative DiseasesJournal of Heterocyclic Chemistry202218 iqtibos

   ABIABI:AkademIndex/2026.other.073026

2. <scp>2‐substituted</scp> tricyclic oxazolo[5,4‐<i>d</i>]pyrimidine library: Design, synthesis, and cytotoxicity activity

   Yan Zeng, Lifei Nie, Khurshed Bozorov +4

   MaqolaQuinazolinone synthesis and applicationsJournal of Heterocyclic Chemistry202112 iqtibos

   ABIABI:AkademIndex/2026.other.073023

3. Synthesis and Biological Activities of Dihydrooxazolo[5,4-<i>d</i>]-pyrrolo[1,2-<i>a</i>]pyrimidinones

   Yan Zeng, Lifei Nie, Chao Niu +4

   MaqolaOAOchiq kirish20229 iqtibos

   ABIABI:AkademIndex/2026.other.073025

4. Design, synthesis, biological evaluation of a new tricyclicthiazolopy‐rimidinone derivatives as acetylcholinesterase inhibitors

   Yan Zeng, Lifei Nie, Liu Liu +2

   MaqolaOAOchiq kirishCholinesterase and Neurodegenerative DiseasesJournal of Heterocyclic Chemistry20243 iqtibos

   ABIABI:AkademIndex/2026.other.285450